Chai Discovery | $70,000,000 | (Aug 7, 2025)
CodeKarma | $2,500,000 | (Aug 7, 2025)
Elion | $9,300,000 | (Aug 7, 2025)
Certified by Founder
Lodge
LyGenesis
start up
United States
- Pittsburgh, Pennsylvania
- 25/10/2023
- Pre Series A
- $19,000,000
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other therapeutic targets for organ regeneration include the thymus, pancreas, and kidney. Privately held, LyGenesis is headquartered in Pittsburgh, Pennsylvania. To learn more, please visit our website at www.lygenesis.com.
- Industry Biotechnology Research
- Website https://www.lygenesis.com/
- LinkedIn https://www.linkedin.com/company/lygenesis/about/
August | $7,000,000 | (Aug 7, 2025)
Stavtar Solutions | $55,000,000 | (Aug 7, 2025)
Tavily | $25,000,000 | (Aug 7, 2025)
Clay | $100,000,000 | (Aug 7, 2025)
Positive Development | $51,500,000 | (Aug 7, 2025)
Kontext | $10,000,000 | (Aug 6, 2025)
Wattch | $6,000,000 | (Aug 6, 2025)
Vendict | $10,000,000 | (Aug 6, 2025)
NuCicer | $11,500,000 | (Aug 6, 2025)